The last decade has seen a substantial increase in research focused on the identification of
blood-based biomarkers that have utility in Alzheimer's disease (AD). Blood-based …

Introduction This study combined data across four independent cohorts to examine the positive
and negative predictive values of an Alzheimer's disease (AD) blood test if implemented …

Aim: To describe the biomarker profiles in elderly Panamanians diagnosed with Alzheimer's
disease (AD), mild cognitive impairment (MCI) or no impairment using serum-based …

Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiologic agent
of the ongoing coronavirus disease 2019 (COVID-19) pandemic, which has reached 28 …

Cognitive impairment and depression are common mental health problems among the elderly,
although few studies have examined their cooccurrence in older adults in Latin America. …

COVID-19 is the name of the acute respiratory disease caused by the new coronavirus
SARS-CoV-2, a close relative of those that caused the severe outbreaks of SARS and MERS …

The adequate choice of Trypanosoma cruzi strains as antigen source for the diagnosis of
Chagas disease is still controversial due to differences in terms of accuracy reported between …

The Latin America and Caribbean region is experiencing one of the fastest rates of population
aging, but research on age-related disability is limited, particularly in Central America. The …

Persistent systemic hypoxia, a direct consequence of alterations in vascular function, can
compromise the brain by increasing the risk of developing dementias such as Alzheimer's …

Research on age-related cognitive impairment is scarce in Central America. We report
factors associated with cognitive impairment among a sample of older adults in Panama …